Bisgin, A. Et Al. 2008. Clinical significance of TRAIL and its receptor expression profiles on CD4+ CD25+ Foxp3+ Tregs and CD8+CD25+ T cells in patients with rheumatoid arthritis. p.134, Brugge, Belgium, 13-16 November 2008. Abstract; Human Gene Therapy 19:1098–1202 (P134), October 2008.. XVth Annual Congress of the European Society of Gene and Cell Therapy (ESGCT), , (Bruge, Belgium), 1098-1202.

Bisgin, A., Ulker, M., YAZISIZ, V., TERZİOĞLU, M. E., & ŞANLIOĞLU, S., (2008). Clinical significance of TRAIL and its receptor expression profiles on CD4+ CD25+ Foxp3+ Tregs and CD8+CD25+ T cells in patients with rheumatoid arthritis. p.134, Brugge, Belgium, 13-16 November 2008. Abstract; Human Gene Therapy 19:1098–1202 (P134), October 2008. . XVth Annual Congress of the European Society of Gene and Cell Therapy (ESGCT), (pp.1098-1202). Bruge, Belgium

Bisgin, Atil Et Al. "Clinical significance of TRAIL and its receptor expression profiles on CD4+ CD25+ Foxp3+ Tregs and CD8+CD25+ T cells in patients with rheumatoid arthritis. p.134, Brugge, Belgium, 13-16 November 2008. Abstract; Human Gene Therapy 19:1098–1202 (P134), October 2008.," XVth Annual Congress of the European Society of Gene and Cell Therapy (ESGCT),, Bruge, Belgium, 2008

Bisgin, Atil Et Al. "Clinical significance of TRAIL and its receptor expression profiles on CD4+ CD25+ Foxp3+ Tregs and CD8+CD25+ T cells in patients with rheumatoid arthritis. p.134, Brugge, Belgium, 13-16 November 2008. Abstract; Human Gene Therapy 19:1098–1202 (P134), October 2008.." XVth Annual Congress of the European Society of Gene and Cell Therapy (ESGCT), , Bruge, Belgium, pp.1098-1202, 2008

Bisgin, A. Et Al. (2008) . "Clinical significance of TRAIL and its receptor expression profiles on CD4+ CD25+ Foxp3+ Tregs and CD8+CD25+ T cells in patients with rheumatoid arthritis. p.134, Brugge, Belgium, 13-16 November 2008. Abstract; Human Gene Therapy 19:1098–1202 (P134), October 2008.." XVth Annual Congress of the European Society of Gene and Cell Therapy (ESGCT), , Bruge, Belgium, pp.1098-1202.

@conferencepaper{conferencepaper, author={Atil Bisgin Et Al. }, title={Clinical significance of TRAIL and its receptor expression profiles on CD4+ CD25+ Foxp3+ Tregs and CD8+CD25+ T cells in patients with rheumatoid arthritis. p.134, Brugge, Belgium, 13-16 November 2008. Abstract; Human Gene Therapy 19:1098–1202 (P134), October 2008.}, congress name={XVth Annual Congress of the European Society of Gene and Cell Therapy (ESGCT),}, city={Bruge}, country={Belgium}, year={2008}, pages={1098-1202} }